Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für neurologische Forschung     Collection: Funktionelle Krebsgenomforschung     Display Documents



  history
ID: 418492.0, MPI für neurologische Forschung / Funktionelle Krebsgenomforschung
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR
Authors:Sos, Martin; Koker, Mirjam; Weir, Barbara; Heynck, Stefanie; Rabinovsky, Rosalia; Zander, Thomas; Seeger, Jens M.; Weiss, Jonathan; Fischer, Florian; Frommolt, Peter; Michel, Kathrin; Peifer, Martin; Mermel, Craig; Girard, Luc; Peyton, Michael; Gazdar, Adi F.; Minna, John D.; Garraway, Levi A.; Kashkar, Hamid; Pao, William; Meyerson, Matthew; Thomas, Roman K.
Language:English
Date of Publication (YYYY-MM-DD):2009-04
Title of Journal:Cancer Research
Volume:69
Issue / Number:8
Start Page:3256
End Page:3261
Review Status:Peer-review
Audience:Experts Only
External Publication Status:published
Document Type:Article
Communicated by:Grasse
Affiliations:MPI für neurologische Forschung/Funktionelle Krebsgenomforschung
External Affiliations:1. Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA
2. Univ Texas SW Med Ctr Dallas, Dept Internal Med & Pharmacol, Dallas, TX 75390 USA
3. Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
4. Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA
5. Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
6. Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA
Identifiers:ISSN:0008-5472
ISI:000265314900004
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.